Jennifer Lachey $KROS SEC Form 4 Insider Trading

Jennifer Lachey has filed a total of 36 insider trades in $KROS since 2021. Their most recent trade was a sale of 46,034 shares, made on Jul 15, 2022. Their largest trade was a sale of 46,034 shares, made on Jul 15, 2022. We estimate that they now own 95,100 shares of $KROS, worth an estimated $6.4 million.

Insider Trading at $KROS

There have been a total of 187 insider trades reported at $KROS since 2021, with 1,191 shares purchased and 1.1 million shares sold. The most active insider traders in $KROS stock have been Jennifer Lachey, Christopher Rovaldi, and Keith Regnante. The most recent trade was a sale of 29,400 shares reported by CARL L GORDON (None), made on Aug 13, 2024.

$KROS Executives and Stock Owners with Insider Trades

• Jennifer Lachey, Chief Scientific Officer

• Christopher Rovaldi, Chief Operating Officer

• Keith Regnante, Chief Financial Officer

• Claudia Ordonez, Chief Medical Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.